Find in Library

The prevalence of antifungal resistance in <i>Candida glabrata</i>, especially against azole drugs, results in difficult-to-treat and potentially life-threatening infections. Understanding the molecular basis of azole resistance in <i>C</i>. <i>glabrata</i> is crucial to designing more suitable therapeutic strategies. In this study, the role of the transcription factor encoded by ORF <i>CAGL0B03421g</i>, here denominated as CgMar1 (Multiple Azole Resistance 1), in azole susceptibility was explored. Using RNA-sequencing, CgMar1 was found to regulate 337 genes under fluconazole stress, including several related to lipid biosynthesis pathways. In this context, CgMar1 and its target <i>CgRSB1</i>, encoding a predicted sphingoid long-chain base efflux transporter, were found to contribute to plasma membrane sphingolipid incorporation and membrane permeability, decreasing fluconazole accumulation. CgMar1 was found to associate with the promoter of <i>CgRSB1</i>, which contains two instances of the CCCCTCC consensus, found to be required for <i>CgRSB1</i> activation during fluconazole stress. Altogether, a regulatory pathway modulating azole susceptibility in <i>C</i>. <i>glabrata</i> is proposed, resulting from what appears to be a neofunctionalization of a Hap1-like transcription factor.